share_log
Reuters ·  Nov 8 07:28
Arcutis Biotherapeutics Inc : Guggenheim Raises Target Price to $29 From $27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment